Clinically isolated syndrome--Rethinking the diagnosis.

Area of Science:

• Neurology
• Immunology
• Diagnostic Medicine

Background:

• Clinically isolated syndrome (CIS) presents diagnostic challenges, with approximately 20% of patients lacking clear prognostic indicators based solely on brain MRI.
• Current diagnostic criteria for CIS often delay early treatment by relying heavily on radiological evidence, overlooking other crucial data.

Purpose of the Study:

• To advocate for the integration of cerebrospinal fluid (CSF) analysis into the diagnostic framework for CIS.
• To highlight the potential for delayed diagnosis in specific ethnic cohorts, such as African Americans, if CSF data are disregarded.

Main Methods:

• Review of existing literature on CIS diagnosis and prognostic factors.
• Analysis of the diagnostic utility of CSF oligoclonal bands (OCBs) in conjunction with MRI findings.
• Examination of potential ethnic variations in CIS presentation and diagnosis.

Main Results:

• Patients with normal MRI but positive CSF OCBs had a significantly higher conversion rate to clinically definite multiple sclerosis (CDMS) (23%) compared to those with normal MRI and negative OCBs (4%).
• Exclusion of CSF data in diagnostic decision-making for CIS can lead to missed opportunities for early intervention.

Conclusions:

• Cerebrospinal fluid analysis, specifically OCB detection, should be incorporated into the diagnostic criteria for CIS to improve prognostic accuracy.
• Further research is urgently needed to investigate ethnic disparities in CIS diagnosis and management, particularly concerning African Americans.